Diagnostics for the Real World (DRW)

Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition

Breakthrough SAMBA II point-of-care diagnostic machine on show to the public from this November, as part of inspiring COVID-19 science showcase.

Diagnostics for the Real World’s multiplex respiratory virus rapid point-of-care tests approved for sale in New Zealand

SAMBA molecular diagnostic tests deliver fast “one sample, one test” detection of COVID-19, FluA/B and RSV in hospital, laboratory and non-laboratory settings.

Transformative Role of SAMBA II in Winchester College’s COVID-19 Response

Many congratulations to Dr John Cullerne, Undermaster at Winchester College, whose pioneering work on COVID-19 was recognised recently with an invitation to Buckingham Palace.

Diagnostics for the Real World (DRW) achieves UK technical validation for two multiplex respiratory virus rapid tests

New combined tests deliver highly accurate point-of-care detection for SARS-CoV-2, Flu A, Flu B and RSV – boosting infection control in hospitals and speeding patient access to urgent care.

New multiplex tests and next-gen SAMBA platform previewed in 360Dx

Dr Helen Lee and COO Craig Wisniewski talk exclusively about DRW's new multiplex assays, plus the company's plans for the third-generation SAMBA platform.

DRW Chairman Dr Helen Lee shares SAMBA COVID-19 journey with UK parliamentary committee

Dr Helen Lee was an invited speaker recently at a key All-Party Parliamentary Group for Life Sciences meeting at Portcullis House in Westminster (March 2022).

SAMBA II showcased in Royal Institution Christmas Lecture

Our CEO Dr Helen Lee features in the iconic The Royal Institution Christmas Lecture series.

SAMBA II COVID-19 in the public eye

Read in newspapers and seen on TV.

Cambridge team develop test that can diagnose Covid-19 in less than 90 minutes

ITV Report 2 April 2020 at 11:30am: New testing devices developed by a Cambridge team that can diagnose Covid-19 in less than 90 minutes are being used at Addenbrooke's Hospital.

Rapid COVID-19 diagnostic test developed by Cambridge team to be introduced in hospitals

A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.

Zimbabwe to leverage on new HIV technology

The Sunday News Zimbabwe, Tinomuda Chakanyuka: SINCE 2016 Martha has been taking HIV viral load tests religiously.

Next Generation SAMBA Whole Blood Viral Load Test receives CE Mark Regulatory Approval

This is not a marketing ploy, we really did just receive CE mark valid from 5th of December 2019 from the Notified Body.

Bringing innovation to the patient: SAMBA POC for HIV and Hepatitis

ICASA Satellite symposium, Wednesday 4th December 2019, 18:30 – 20:30, Room Joel Nana (AD10)

Highlights from a live demonstration of point-of-care hepatitis C and hepatitis B diagnostic tests

DRW participates in a live demonstration of point-of-care hepatitis C and hepatitis B diagnostic tests hosted by FIND.

DRW wins Innovate UK's Design in Innovation Award

A shortlist of 10 firms competed for Innovate UK’s Design in Innovation award, and Diagnostics for the Real World was recognized for the development of the SAMBA platform.

DRW presents at ASLM Cape Town

DRW were once again in attendance at the annual ASLM this year held in Cape Town, South Africa.

Helen Lee wins European Inventor Award 2016

Helen Lee has won the European Inventor Award 2016 Popular Prize from the European Patent Office (EPO)!